WIN-35428
| Clinical data | |
|---|---|
| Other names | CFT, WIN 35,428 |
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number |
|
| PubChem CID | |
| IUPHAR/BPS | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.164.866 |
| Chemical and physical data | |
| Formula | C16H20FNO2 |
| Molar mass | 277.339 g·mol−1 |
| 3D model (JSmol) | |
| Specific rotation | -62.5° |
| Melting point | 202 to 204 °C (396 to 399 °F) |
| |
| |
| (what is this?) (verify) | |
WIN 35,428 (β-CFT, (–)-2-β-Carbomethoxy-3-β-(4-fluorophenyl)tropane) is a stimulant drug used in scientific research. CFT is a phenyltropane based dopamine reuptake inhibitor and is structurally derived from cocaine. It is around 3-10x more potent than cocaine and lasts around 7 times longer based on animal studies. While the naphthalenedisulfonate salt is the most commonly used form in scientific research due to its high solubility in water, the free base and hydrochloride salts are known compounds and can also be produced. The tartrate is another salt form that is reported.